ENG

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, ENG mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ENG data layer compared with 29 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher ENG mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ENG expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.

PDAC, UCEC, and GBM are the cancer types where ENG mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
PDACDFSTertileIII,IV0.9840.365.00138view →
UCECDFSQuartileII,III,IV0.3720.898.0248view →
GBMOSTertileAll0.3710.636.0146view →
LSCCOSQuartileII,III,IV0.5010.934.0145view →
HNSCDFSQuartileAll0.6290.844.0412view →
Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ENG–PDAC (DFS)

Kaplan–Meier survival curve for ENG mass-spec protein-high vs -low samples in PDAC.

Open the PDAC breakdown →

Exploration